Profil
Paul Dick is currently a Partner at Vet Venture Capital, Inc. He was previously the Chief Executive Officer & Director at Avivagen, Inc. from 2008 to 2010.
He also served as a Director at AbCelex Technologies, Inc. Dr. Dick holds a doctorate degree from the University of Guelph.
Aktive Positionen von Paul Dick
| Unternehmen | Position | Beginn |
|---|---|---|
Vet Venture Capital, Inc.
Vet Venture Capital, Inc. Investment ManagersFinance Vet Venture Capital invests in companies operating in the fields of food & companion animal health markets that develop pharmaceuticals, vaccines, diagnostics, science-based wellness products and drug delivery mechanisms. The firm initially invests in the range of $100K to $5 million and also participates in the follow-on rounds of investments. It acts as a lead investor, along with con-investments and takes both minority & majority interests, also seeks board seat requirement. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Paul Dick
| Unternehmen | Position | Ende |
|---|---|---|
| AVIVAGEN INC. | Präsident | 01.10.2010 |
AbCelex Technologies, Inc.
AbCelex Technologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Direktor/Vorstandsmitglied | - |
Ausbildung von Paul Dick
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Guelph
University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avivagen, Inc.
Avivagen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes health supplements for animals & pets | Commercial Services |
Vet Venture Capital, Inc.
Vet Venture Capital, Inc. Investment ManagersFinance Vet Venture Capital invests in companies operating in the fields of food & companion animal health markets that develop pharmaceuticals, vaccines, diagnostics, science-based wellness products and drug delivery mechanisms. The firm initially invests in the range of $100K to $5 million and also participates in the follow-on rounds of investments. It acts as a lead investor, along with con-investments and takes both minority & majority interests, also seeks board seat requirement. | Finance |
AbCelex Technologies, Inc.
AbCelex Technologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
















